Richard's Pharma Limited - Accounts to registrar (filleted) - small 18.2

Richard's Pharma Limited - Accounts to registrar (filleted) - small 18.2

RICHARD'S PHARMA LIMITED - Company Information

Print Friendly Version

IRIS Accounts Production v21.4.0.171 05392001 Board of Directors 31.3.20 30.3.21 30.3.21 0 0 true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure053920012020-03-30053920012021-03-30053920012020-03-312021-03-30053920012019-03-31053920012019-04-012020-03-30053920012020-03-3005392001ns16:EnglandWales2020-03-312021-03-3005392001ns15:PoundSterling2020-03-312021-03-3005392001ns11:Director12020-03-312021-03-3005392001ns11:PrivateLimitedCompanyLtd2020-03-312021-03-3005392001ns11:SmallEntities2020-03-312021-03-3005392001ns11:AuditExempt-NoAccountantsReport2020-03-312021-03-3005392001ns11:SmallCompaniesRegimeForDirectorsReport2020-03-312021-03-3005392001ns11:SmallCompaniesRegimeForAccounts2020-03-312021-03-3005392001ns11:FullAccounts2020-03-312021-03-3005392001ns11:Director22020-03-312021-03-3005392001ns11:CompanySecretary12020-03-312021-03-3005392001ns11:RegisteredOffice2020-03-312021-03-3005392001ns6:CurrentFinancialInstruments2021-03-3005392001ns6:CurrentFinancialInstruments2020-03-3005392001ns6:ShareCapital2021-03-3005392001ns6:ShareCapital2020-03-3005392001ns6:RetainedEarningsAccumulatedLosses2021-03-3005392001ns6:RetainedEarningsAccumulatedLosses2020-03-3005392001ns6:CostValuation2020-03-3005392001ns6:CostValuation2021-03-3005392001ns6:CurrentFinancialInstrumentsns6:WithinOneYear2021-03-3005392001ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-03-3005392001ns6:Non-currentFinancialInstruments2021-03-3005392001ns6:Non-currentFinancialInstruments2020-03-30
REGISTERED NUMBER: 05392001 (England and Wales)




UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 MARCH 2021

FOR

RICHARD'S PHARMA LIMITED
RICHARD'S PHARMA LIMITED (REGISTERED NUMBER: 05392001)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 30 March 2021




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


RICHARD'S PHARMA LIMITED

COMPANY INFORMATION
for the year ended 30 March 2021







DIRECTORS: S E Taylor
L D Taylor





SECRETARY: L D Taylor





REGISTERED OFFICE: Taylor Group House
Wedgnock Lane
Warwick
Warwickshire
CV34 5YA





REGISTERED NUMBER: 05392001 (England and Wales)





ACCOUNTANTS: LDP Luckmans
1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB
Page 1
RICHARD'S PHARMA LIMITED (REGISTERED NUMBER: 05392001)

BALANCE SHEET
30 March 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Investments 4 279,535 279,535

CURRENT ASSETS
Debtors 5 6,558,667 5,693,036
Cash at bank 168,200 236,789
6,726,867 5,929,825
CREDITORS
Amounts falling due within one year 6 2,038,399 1,742,970
NET CURRENT ASSETS 4,688,468 4,186,855
TOTAL ASSETS LESS CURRENT
LIABILITIES
4,968,003
4,466,390

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 4,967,903 4,466,290
SHAREHOLDERS' FUNDS 4,968,003 4,466,390

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 March 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 March 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 December 2021 and were signed on its behalf by:





S E Taylor - Director


The notes form part of these financial statements

Page 2
RICHARD'S PHARMA LIMITED (REGISTERED NUMBER: 05392001)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 30 March 2021

1. STATUTORY INFORMATION

Richard's Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Investments in subsidiaries and associates
Investments in subsidiary and associate undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2020 - NIL).

Page 3 continued...
RICHARD'S PHARMA LIMITED (REGISTERED NUMBER: 05392001)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 March 2021

4. FIXED ASSET INVESTMENTS
Shares in Interest
group in
undertakings associate Totals
£    £    £   
COST
At 31 March 2020
and 30 March 2021 266,535 13,000 279,535
NET BOOK VALUE
At 30 March 2021 266,535 13,000 279,535
At 30 March 2020 266,535 13,000 279,535

5. DEBTORS
2021 2020
£    £   
Amounts falling due within one year:
Trade debtors (1,151 ) (1,151 )
Amounts owed by group undertakings 1,654,751 991,474
Other debtors 339,002 158,000
VAT 13,662 16,548
Prepayments and accrued income 52,403 28,165
2,058,667 1,193,036

Amounts falling due after more than one year:
Amounts owed by group undertakings 4,500,000 4,500,000

Aggregate amounts 6,558,667 5,693,036

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade creditors 5,613 12,408
Tax - 5,776
Other creditors - 56,600
Directors' current accounts 2,030,286 1,665,436
Accrued expenses 2,500 2,750
2,038,399 1,742,970

Page 4